These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34339121)

  • 21. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
    Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Comparison of Toll-Like Receptor 5 and 21 Ligands as Adjuvants for a Formaldehyde Inactivated H9N2 Avian Influenza Virus Vaccine in Chickens.
    Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Shojadoost B; Petrik JJ; Nagy É; Sharif S
    Viral Immunol; 2018 Nov; 31(9):605-612. PubMed ID: 30222508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low pathogenic avian influenza (H9N2) in chicken: Evaluation of an ancestral H9-MVA vaccine.
    Ducatez MF; Becker J; Freudenstein A; Delverdier M; Delpont M; Sutter G; Guérin JL; Volz A
    Vet Microbiol; 2016 Jun; 189():59-67. PubMed ID: 27259828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective efficacy of an inactivated vaccine against H9N2 avian influenza virus in ducks.
    Teng Q; Shen W; Liu Q; Rong G; Chen L; Li X; Chen H; Yang J; Li Z
    Virol J; 2015 Sep; 12():143. PubMed ID: 26377565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-infection of
    Arafat N; Abd El Rahman S; Naguib D; El-Shafei RA; Abdo W; Eladl AH
    Avian Pathol; 2020 Oct; 49(5):496-506. PubMed ID: 32835500
    [No Abstract]   [Full Text] [Related]  

  • 26. Pathogenicity and Full Genome Sequencing of the Avian Influenza H9N2 Moroccan Isolate 2016.
    Boumart Z; Bamouh Z; Jazouli M; Zecchin B; Fusaro A; Salviato A; Monne I; Tadlaoui KO; Harrak ME
    Avian Dis; 2019 Mar; 63(1):24-30. PubMed ID: 31251516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the Protective Efficacy of Poly I:C as an Adjuvant for H9N2 Subtype Avian Influenza Inactivated Vaccine and Its Mechanism of Action in Ducks.
    Zhang A; Lai H; Xu J; Huang W; Liu Y; Zhao D; Chen R
    PLoS One; 2017; 12(1):e0170681. PubMed ID: 28135294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In ovo administration of retinoic acid enhances cell-mediated immune responses against an inactivated H9N2 avian influenza virus vaccine.
    Alizadeh M; Raj S; Shojadoost B; Matsuyama-Kato A; Boodhoo N; Abdelaziz K; Sharif S
    Vaccine; 2023 Nov; 41(48):7281-7289. PubMed ID: 37923694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative immune response and pathogenicity of the H9N2 avian influenza virus after administration of Immulant
    Eladl AH; Arafat N; El-Shafei RA; Farag VM; Saleh RM; Awadin WF
    Comp Immunol Microbiol Infect Dis; 2019 Aug; 65():165-175. PubMed ID: 31300109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced cross-lineage protection induced by recombinant H9N2 avian influenza virus inactivated vaccine.
    Wang Z; Li Z; Su X; Qiao Y; Fan W; Li H; Shi B; Qin T; Chen S; Peng D; Liu X
    Vaccine; 2019 Mar; 37(13):1736-1742. PubMed ID: 30797637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Examination of the effects of virus inactivation methods on the induction of antibody- and cell-mediated immune responses against whole inactivated H9N2 avian influenza virus vaccines in chickens.
    Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Bavananthasivam J; Nagy É; Petrik JJ; Sharif S
    Vaccine; 2018 Jun; 36(27):3908-3916. PubMed ID: 29853199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of an effective contemporary trivalent avian influenza vaccine against circulating H5N1, H5N8, and H9N2 in Egypt.
    Gomaa MR; Khalil AA; Kandeil A; Sabir JSM; Kayed A; Moatasim Y; El Saied MF; El-Safty MM; Kayali G; Ali MA
    Poult Sci; 2019 Dec; 98(12):6289-6295. PubMed ID: 31265106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral immunization with an attenuated
    Hajam IA; Kirthika P; Hewawaduge C; Jawalagatti V; Park S; Senevirathne A; Lee JH
    Avian Pathol; 2020 Oct; 49(5):486-495. PubMed ID: 32483989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective efficacy of H5 inactivated vaccines in meat turkey poults after challenge with Egyptian variant highly pathogenic avian influenza H5N1 virus.
    Kilany WH; Abdelwhab EM; Arafa AS; Selim A; Safwat M; Nawar AA; Erfan AM; Hassan MK; Aly MM; Hafez HM
    Vet Microbiol; 2011 May; 150(1-2):28-34. PubMed ID: 21236607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.
    Kilany WH; Safwat M; Mohammed SM; Salim A; Fasina FO; Fasanmi OG; Shalaby AG; Dauphin G; Hassan MK; Lubroth J; Jobre YM
    PLoS One; 2016; 11(6):e0156747. PubMed ID: 27304069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the protective efficacy of a commercial vaccine against different antigenic groups of H9N2 influenza viruses in chickens.
    Sun Y; Pu J; Fan L; Sun H; Wang J; Zhang Y; Liu L; Liu J
    Vet Microbiol; 2012 Apr; 156(1-2):193-9. PubMed ID: 22019289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental co-infection of infectious bronchitis and low pathogenic avian influenza H9N2 viruses in commercial broiler chickens.
    Hassan KE; Ali A; Shany SAS; El-Kady MF
    Res Vet Sci; 2017 Dec; 115():356-362. PubMed ID: 28692924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective Efficacy of Inactivated H9N2 Vaccine in Turkey Poults under Both Experimental and Field Conditions.
    Elfeil WK; Youssef H; Sedeek A; El-Shemy A; Abd-Allah EM; Elkady MF; El Sayed EK; Bazid AI; Abdallah MS
    Vaccines (Basel); 2022 Dec; 10(12):. PubMed ID: 36560588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination against H9N2 avian influenza virus reduces bronchus-associated lymphoid tissue formation in cynomolgus macaques after intranasal virus challenge infection.
    Nakayama M; Ozaki H; Itoh Y; Soda K; Ishigaki H; Okamatsu M; Sakoda Y; Park CH; Tsuchiya H; Kida H; Ogasawara K
    Pathol Int; 2016 Dec; 66(12):678-686. PubMed ID: 27910264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. H9N2 avian influenza virus-induced conjunctivitis model for vaccine efficacy testing.
    Kim IH; Kwon HJ; Kimabce JH
    Avian Dis; 2013 Mar; 57(1):83-7. PubMed ID: 23678734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.